מיפג'ין

País: Israel

Idioma: hebreu

Font: Ministry of Health

ingredients actius:

MIFEPRISTONE

Disponible des:

A. LAPIDOT PHARMACEUTICALS, LTD

Codi ATC:

G03XB01

formulario farmacéutico:

טבליה

Composición:

MIFEPRISTONE 200 MG

Vía de administración:

פומי

tipo de receta:

מרשם נדרש

Fabricat per:

EXELGYNE LABORATORIES, FRANCE

Grupo terapéutico:

MIFEPRISTONE

Área terapéutica:

MIFEPRISTONE

indicaciones terapéuticas:

Medical alternative to uterine suction for termination of intra-utrerine Pregnancy: - up to and no later than 49 days of amenorrhea (seven weeks) - in sequential use with a prostaglandin analogue misoprostol 400 mcg per os administered 36 to 48 hours after Mifegyne intake. Under these conditions the association of mifepristone and prostaglandins leads to a success rate of about 95 per cent of the cases. Preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reason (beyond the first trimester). Softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester.

Data d'autorització:

2014-07-31